Skip to main content

Table 3 The status of axillary lymph node (ALN) after neoadjuvant chemotherapy in group B

From: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration

ALN

Non-sentinel node

Total

Positive

Negative

 

Sentinel node

   

Positive

14

11

25

Negative

3

26

29

Total

17

37

54

  1. False negative rate 10.7 % (3/(25 + 3);95 % CI, 2–28 %),Overall accuracy 94.4 % ((25 + 26)/54;95 % CI, 88–99 %),Sensitivity rate 89.3 % (25/(25 + 3);95 % CI, 72–98 %)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us